Live streamed, On demand, FOYA awards, 5k run, Neworking events, Deep dive training, & More
View Conference Experience
Learn from industry experts.
Michael Kopcha, Ph.D., RPh, Thomas Wozniewski, Ph.D., Lita Sands, & Robert Weker
Showcase your solutions and services in front of key industry decision-makers.
The 2022 ISPE Annual Meeting & Expo will usher in a revitalized focus on excellence, modernization, and harmonization in pharmaceutical science and manufacturing across the globe, offering pharma professionals the opportunity to engage in industry-critical conversations. A comprehensive education program provides attendees with technical sessions on the latest developments in supply chain, operations, facilities, equipment, information systems, product development, production systems, quality systems, regulatory guidance and cutting-edge industry innovations. This signature event draws pharmaceutical and biopharmaceutical professionals at all levels of the industry from emerging leaders to the most senior executives in drug manufacturing, supply chain, devices and equipment and services, and global regulatory agencies. The conference Partner Showcase presents a large offering of the latest technologies and services for the pharmaceutical industry.
Education Tracks and Sessions will be focused on topics critical to our industry and regulatory members.
Digitalization and the management of big data plus its analytics enables the control, prediction, and optimization of related biopharmaceutical business management trends and processes. The Digital Transformation process comprises the organization requirements, cultural change, workforce training and infrastructure required for successful implementation. This includes the 4 principles of Pharma 4.0 - Resources, Organization, Culture and Information Systems.
Applying harmonized approaches to innovative design solutions and project delivery strategies to ensure that quality therapeutic products are brought to market in an efficient manner to improve patient health. This includes manufacturing process improvement, the business strategies, and technology associated with the future state of manufacturing.
Regulatory and quality challenges, learnings, and opportunities which might include the current speed to market expectations, pandemic management, drug shortages, and the regulatory focus on data integrity.
The impact and potential utilization of new technologies, processes, and disruptions on operations and logistics of the production of all types of therapies.
Emerging and evolving technologies and practices that are helping drive a revolution in medicinal therapies, analytical techniques, manufacturing paradigms, medical devices including novel methods to deliver the next generation of drugs to patients.